BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7137822)

  • 1. Toxic epidermal necrolysis-case report and review of the literature.
    Ortiz JE; Horn MS; Peterson HD
    Ann Plast Surg; 1982 Sep; 9(3):249-53. PubMed ID: 7137822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.
    Rijal JP; Pompa T; Giri S; Bhatt VR
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25008332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of toxic epidermal necrolysis in a pediatric burn center.
    Adzick NS; Kim SH; Bondoc CC; Quinby WC; Remensnyder JP
    Am J Dis Child; 1985 May; 139(5):499-502. PubMed ID: 3920898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wildermuth A
    JAAPA; 2020 Aug; 33(8):48-49. PubMed ID: 32740115
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic epidermal necrolysis. A widespread, life-threatening blistering reaction.
    Watanakunakorn P; Brodell RT
    Postgrad Med; 2000 Apr; 107(4):29-30. PubMed ID: 10778408
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic epidermal necrolysis and co-trimoxazole.
    Whittington RM
    Lancet; 1989 Sep; 2(8662):574. PubMed ID: 2570281
    [No Abstract]   [Full Text] [Related]  

  • 8. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute epidermal necrolysis or Lyell syndrome.
    Sluysmans T; De Bont B; Cornu G
    Eur J Pediatr; 1987 Mar; 146(2):199-200. PubMed ID: 3569362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
    Ugburo AO; Temiye EO; Ilombu CA
    Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis associated with pembrolizumab.
    Cai ZR; Lecours J; Adam JP; Marcil I; Blais N; Dallaire M; Belisle A; Mathieu A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1259-1265. PubMed ID: 31810421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis due to cotrimoxazole.
    Lipozencic J; Milavec-Puretic V; Kotrulja L; Tomicic H; Stulhofer Buzina D
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):182-3. PubMed ID: 12046835
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
    Gavigan GM; Kanigsberg ND; Ramien ML
    J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the cutaneous involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis with silver nitrate-impregnated dressings.
    Lehrer-Bell KA; Kirsner RS; Tallman PG; Kerdel FA
    Arch Dermatol; 1998 Jul; 134(7):877-9. PubMed ID: 9681360
    [No Abstract]   [Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Biobrane in the treatment of toxic epidermal necrolysis.
    Kucan JO
    J Burn Care Rehabil; 1995; 16(3 Pt 1):324-7; discussion 327-8. PubMed ID: 7673317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Mistry RD; Schwab SH; Treat JR
    Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
    Schwartz RA; McDonough PH; Lee BW
    J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch testing in an unusual case of toxic epidermal necrolysis.
    Klein CE; Trautmann A; Zillikens D; Bröcker EB
    Contact Dermatitis; 1995 Dec; 33(6):448-9. PubMed ID: 8706422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.